GENE ONLINE|News &
Opinion
Blog

RSV vaccines
GSK Wins Approval For World’s First RSV Vaccine
2023-05-08
Pfizer and GSK Neck and Neck for First FDA-Approved RSV Vaccine
2023-03-03
Pfizer’s RSV Vaccine Wins Support From FDA Advisory Panel for Use in Older Adults
2023-03-01
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
CDC Warns Of “Tripledemic” Winter Amid Rising Flu And RSV Cases
2022-11-14
The First Approved RSV Vaccine Worldwide Belongs to AstraZeneca and Sanofi
2022-11-06
GSK’s RSV Vaccine Candidate Has Won Another Regulatory Review
2022-11-03
GSK Posts Stellar Results from Phase 3 RSV Vaccine Trial
2022-10-13
AstraZeneca, Sanofi’s RSV Antibody Recommended For Approval In EU
2022-09-19
Pfizer’s Bivalent RSV Candidate Demonstrates 85% Efficacy in Phase 3 Trials
2022-08-26
ReViral Acquisition by Pfizer To Enhance Its Respiratory Syncytial Virus Therapeutic Portfolio
2022-04-10
LATEST
From Sweet to Risky: The Alarming Findings on Sucralose’s Genotoxicity
2023-06-07
GHG Emissions as a ESG Metric
2023-06-07
NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO’s Demo Day
2023-06-07
Krystal Biotech’s First Topical Gene Therapy Approved by FDA
2023-06-06
The Emergence of General AI for Medicine: Medical Applications of ChatGPT
2023-06-06
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
2023-06-05
Scroll to Top